A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/03/2004	CN1542011A Sulphur containing heterocyclic and naphthalimides compound and use thereof
11/03/2004	CN1542004A Tyrosine kinase inhibitor, preparation method and use thereof
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1541713A Cross-breed vaccine carrier and its application
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1541699A Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process
11/03/2004	CN1541668A Osteopathy treating ointment
11/03/2004	CN1541662A Medicine for treating esophagus cancer and gastric cancer, and its preparation
11/03/2004	CN1541656A Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173996C Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application
11/03/2004	CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173990C Depsipeptide compound
11/03/2004	CN1173976C Use of antineoplastic active compound nitrene-phin
11/03/2004	CN1173975C Imidazopyridine derivatives
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173948C Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004	CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004	CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
11/03/2004	CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004	CN1173736C Use of interleukin-18 inhibitors in inhibiting tumor metastasis
11/03/2004	CN1173726C Medicine for curing malignant turnor and its preparation method
11/03/2004	CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/02/2004	US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004	US6812362 Amidation; efficiency, higher yields, performed at or near room temperature, energy savings
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812258 Cancer treatment composition and method using natural plant essential oils
11/02/2004	US6812255 Use of aloe-emodin in the treatment of neuroectodermal tumors
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812246 Trifluoroaminoflavone compounds which are substituted with amine-containing groups at the 5- and/or 4'- flavone ring position; water solubility and solubility in organic solvents; antitumor and anticarciogenic agents
11/02/2004	US6812245 Polycylic xanthones and their use
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812232 Heterocycle substituted purine derivatives as potent antiproliferative agents
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812209 Conjugate consisting of an active substance and a non-exogenous native protein
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812037 Antimitotic compounds
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
11/02/2004	US6811788 Combinations and methods for treating neoplasms
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811775 Reovirus for the treatment of cellular proliferative disorders
11/02/2004	US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004	CA2153903C Process for the preparation of 10-desacetoxybaccatin iii
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
10/2004
10/30/2004	CA2429139A1 Treatment of hormone-refractory prostate cancer
10/28/2004	WO2004092388A1 Vector
10/28/2004	WO2004092374A1 METHOD OF REGULATING ACTIVATION OF TRANSCRIPTIONAL FACTORS NF-AT, AP-1 AND NF-κB USING EFFECT OF ACTIVATING ADAPTOR PROTEIN 3BP2
10/28/2004	WO2004092373A1 Peptide having htlv-1-specific ctl-inducing activity
10/28/2004	WO2004092216A1 Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092205A1 Hydroxy-substituted-20-acyloxy-camptothecin polymer derivatives and use of the same for the manufacture of a medicament
10/28/2004	WO2004092204A1 Identification of n-alkylglycine trimers for induction of apoptosis
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004	WO2004092154A1 Compositions useful as inhibitors of protein kinases
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092139A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092118A2 2-propylidene-19-nor-vitamin d compounds
10/28/2004	WO2004091669A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
10/28/2004	WO2004091668A1 Thorium-227 for use in radiotherapy of soft tissue disease
10/28/2004	WO2004091664A1 Cytoplasmic malate dehydrogenase inhibitor
10/28/2004	WO2004091650A1 Application of cardiac troponin i in preparing antitumour medicaments
10/28/2004	WO2004091641A1 Follicle-stimulating hormone releasing agent
10/28/2004	WO2004091637A2 System capable of treating and defining various diseases using stem cells
10/28/2004	WO2004091636A1 Phosphate derivatives of pharmaceutical products
10/28/2004	WO2004091635A1 Remedy for endometriosis and gynecologic diseases
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091621A1 Alternating treatment of cancer with topoisomerase i and topoisomerase ii inhibitors
10/28/2004	WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	WO2004091594A1 Use of geraniol in antitumoral therapy
10/28/2004	WO2004091490A2 Somatostatin-dopamine chimeric analogs
10/28/2004	WO2004080379A3 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect
10/28/2004	WO2004076444A3 Novel hydroxycoumaranone derivatives as antitumor and antimetastatic
10/28/2004	WO2004076386A3 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
10/28/2004	WO2004074502A3 A process of preparing imatinib
10/28/2004	WO2004067023A3 Survivin-derived peptides and use thereof
10/28/2004	WO2004058791A3 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/28/2004	WO2004056827A3 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/28/2004	WO2004047925A3 Therapeutic oxidation catalysts
10/28/2004	WO2004038374A3 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
10/28/2004	WO2004022099A3 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
10/28/2004	WO2004012817A3 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
10/28/2004	WO2004005349A3 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	WO2003105908A3 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004	WO2003087126A3 Heteroclitic analogs and related methods

1 ... 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 ... 2211